Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A

European Journal of Pharmacology

Volumn 461, Issue 2-3, 2003, Pages 89-92

  Ma, Xiaochao ^a   Wang, Haixue ^b   Xin, Jian ^a   Zhang, Ting ^a   Tu, Zenghong ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cytochrome P450; Huperzine A; Metabolism; Microsome

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C11; CYTOCHROME P450 2E1; CYTOCHROME P450 3A1; CYTOCHROME P450 3A2; ENZYME ANTIBODY; HUPERZINE A; PHENACETIN;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOMODULATION; IN VITRO STUDY; LIVER MICROSOME; MALE; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 12244291292     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01290-1     Document Type: Article

References (18)

1. Bai D.L., Tang X.C., He X.C. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease. Curr. Med. Chem. 7:2000;355-374.
2. Curtis J.O., Rory P.R., Vinayak P.H. Concise review of the cytochrome P450 isoenzymes and their roles in toxicology. Toxicol. Sci. 48:1999;151-156.
3. Gelboin H.V. Cytochrome P450 and monoclonal antibodies. Pharmacol. Rev. 45:1993;413-453.
4. Gibbson G.G., Shett P. Introduction to Drug Metabolism. 2nd ed. 1994;Blackie Academic and Professional, London.
5. Gonzalez F.J. Molecular genetics of the P-450 superfamily. Pharmacol. Ther. 45:1990;1-38.
6. Guengerich F.P. Catalytic selectivity of rat cytochrome P450 enzymes: relevance to drug metabolism and toxicity. Toxicol. Lett. 70:1994;133-138.
7. Guengerich F.P., Shimada T. Oxidation of toxic and carcinogenic chemicals by cytochrome P450 enzymes. Chem. Res. Toxicol. 4:1991;391-407.
8. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folinphenol reagent. J. Biol. Chem. 193:1951;265-275.
9. Pearce R.E., Rodrigues A.D., Goldstein J.A., Parkinson A. Identification of the rat P450 enzymes involved in lansoprazole metabolism. J. Pharmacol. Exp. Ther. 277:1996;805-816.
10. Qian B.C., Wang M., Zhou Z.F., Chen K., Zhou R.R., Chen G.S. Pharmacokinetics of tablet Huperzine A in six volunteers. Acta Pharmacol. Sin. 16:1995;396-398.
11. Rendic S., Di Carlo F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug. Metab. Rev. 29:1997;413-580.
12. Roberts E.A., Furuya K.N., Tang B.K., Kalow W. Caffeine biotransformation in rat hepatocyte lines derived from normal liver tissue. Biochem. Biophys. Res. Commun. 201:1994;559-566.
13. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual variations in rat liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270:1994;414-423.
14. Shou M.G., Lu T., Krausz K.W., Sai Y., Yang T.J., Korzekwa K.R., Gonzalez F.J., Gelboin H.V. Use of inhibitory monoclonal antibodies to assess the contribution of cytochrome P450 to rat drug metabolism. Eur. J. Pharmacol. 394:2000;199-209.
15. Svensson U.S.H., Ashton M. Identification of the cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin. Br. J. Clin. Pharmacol. 48:1999;528-535.
16. Tassaneeyakul W., Birkett D.J., Veronese M.E., McManus M.E., Tukey R.H., Quattrochi L.C., Gelboin H.V., Miners J.O. Specificity of substrate and inhibitor probes for rat cytochrome P4501A1 and 1A2. J. Pharmacol. Exp. Ther. 265:1993;401-407.
17. Wang Y.E., Feng J., Lu W.H., Tang X.C. Pharmacokinetics of Huperzine A in rats and mice. Acta Pharmacol. Sin. 9:1998;193-196.
18. Xu Z.H., Zhou H.H. Cytochrome P4501A2 in drug metabolism. Chin. J. Clin. Pharmacol. 12:1996;115-121.